Abstract
A genotyping study of 285 Hybrid Capture 2 low-risk probe cocktail-positive specimens showed cross-reactivity with several untargeted human papillomavirus genotypes. Cross-reactivity was often clinically beneficial due to the detection of untargeted low-risk genotypes. A total of 8.4% of positive results, usually weak, were due to cross-reactivity with high-risk genotypes. Establishment of a gray zone is recommended.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Cross Reactions
-
DNA, Viral / genetics*
-
DNA, Viral / isolation & purification*
-
Female
-
Genotype
-
Humans
-
Nucleic Acid Hybridization / methods*
-
Oligonucleotide Probes / genetics
-
Papillomaviridae / classification*
-
Papillomaviridae / genetics
-
Papillomaviridae / isolation & purification*
-
Papillomavirus Infections / diagnosis*
-
Sensitivity and Specificity
-
Young Adult
Substances
-
DNA, Viral
-
Oligonucleotide Probes